title: Does upsizing statins have a downside?
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Brown
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D009135:Muscular Diseases / Q000139:chemically induced*; D018570:Risk Assessment
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
references.citation: Am J Cardiovasc Drugs. 2008;8(6):373-418
references.pmid: 19159124
references.citation: Nat Med. 2010 Feb;16(2):150-3
references.pmid: 20134459
references.citation: Med J Aust. 2009 Sep 21;191(6):324-9
references.pmid: 19769555
references.citation: Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14
references.pmid: 16453090
references.citation: Drug Saf. 2010 Mar 1;33(3):171-87
references.pmid: 20158283